Clinical Trial Update: Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout [Phase 4]

View source ↗

Summary

This clinical trial update notes a Phase 4 study comparing treat-to-target serum urate with treat-to-avoid symptoms in gout, currently recruiting at Massachuset…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Gout | Phase 4 | Status: RECRUITING